VOLUNTARY TERMINATION OF PREGNANCY WITH MIFEPRISTONE RU486 AND MISOPROSTOL - MIFEPRISTONE AND MISOPROSTOL

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-004940-29-IT

Enrollment

400

Registered

2006-01-24

Start date

2005-01-13

Completion date

Unknown

Last updated

2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VOLUNTARY TERMINATION OF PREGNANCY LAW N.194/1978 MedDRA version: 6.1 Level: PT Classification code 10000220

Interventions

Trade Name: Mifegyne Pharmaceutical Form: Tablet INN or Proposed INN: Mifepristone Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 200- Product Name: Misoprostol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PREGNANCY INTRAUTERINE OF 49 DAYS AND REQUEST OF VTO Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: INTRAUTERINE PREGNANCY

Design outcomes

Primary

Measure	Time frame
Main Objective: VOLUNTARY TERMINATION OF PREGNANCY WITH 200 MG AND 600 MG OF MIFEPRISTONE;Secondary Objective: ACCEPTABILITY OF THE METHODS AND COMPLICATION;Primary end point(s): PERCENTAGE OF SUCCESS	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026